ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 72 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,000 | -60.0% | 3,517 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | -54.5% | 3,517 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | 0.0% | 3,517 | 0.0% | 0.00% | – |
| Q2 2016 | $11,000 | -15.4% | 3,517 | 0.0% | 0.00% | – |
| Q1 2016 | $13,000 | +30.0% | 3,517 | +63.8% | 0.00% | – |
| Q4 2015 | $10,000 | – | 2,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
| Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
| Abingworth LLP | 437,994 | $679,000 | 0.19% |
| GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
| BVF INC/IL | 559,624 | $884,000 | 0.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
| Perceptive Advisors | 503,156 | $795,000 | 0.07% |
| Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
| Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |